CERS
Price
$1.23
Change
-$0.02 (-1.60%)
Updated
Sep 12 closing price
Capitalization
235.79M
45 days until earnings call
XAIR
Price
$2.43
Change
+$0.17 (+7.52%)
Updated
Sep 12 closing price
Capitalization
12.7M
63 days until earnings call
Interact to see
Advertisement

CERS vs XAIR

Header iconCERS vs XAIR Comparison
Open Charts CERS vs XAIRBanner chart's image
Cerus
Price$1.23
Change-$0.02 (-1.60%)
Volume$686.01K
Capitalization235.79M
Beyond Air
Price$2.43
Change+$0.17 (+7.52%)
Volume$515.36K
Capitalization12.7M
CERS vs XAIR Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. XAIR commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and XAIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (CERS: $1.23 vs. XAIR: $2.43)
Brand notoriety: CERS and XAIR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CERS: 63% vs. XAIR: 13%
Market capitalization -- CERS: $235.79M vs. XAIR: $12.7M
CERS [@Medical/Nursing Services] is valued at $235.79M. XAIR’s [@Medical/Nursing Services] market capitalization is $12.7M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.75B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CERS and XAIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 3 TA indicator(s) are bullish while XAIR’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 3 bullish, 4 bearish.
  • XAIR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CERS and XAIR are a bad buy in the short-term.

Price Growth

CERS (@Medical/Nursing Services) experienced а -7.52% price change this week, while XAIR (@Medical/Nursing Services) price change was +9.95% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.34%. For the same industry, the average monthly price growth was +3.98%, and the average quarterly price growth was +29.53%.

Reported Earning Dates

CERS is expected to report earnings on Oct 30, 2025.

XAIR is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($236M) has a higher market cap than XAIR($12.7M). CERS YTD gains are higher at: -20.130 vs. XAIR (-66.109). CERS has higher annual earnings (EBITDA): -8.62M vs. XAIR (-37.23M). CERS has more cash in the bank: 78M vs. XAIR (6.46M). XAIR has less debt than CERS: XAIR (13.7M) vs CERS (98.9M). CERS has higher revenues than XAIR: CERS (193M) vs XAIR (4.78M).
CERSXAIRCERS / XAIR
Capitalization236M12.7M1,858%
EBITDA-8.62M-37.23M23%
Gain YTD-20.130-66.10930%
P/E RatioN/AN/A-
Revenue193M4.78M4,036%
Total Cash78M6.46M1,207%
Total Debt98.9M13.7M722%
FUNDAMENTALS RATINGS
CERS vs XAIR: Fundamental Ratings
CERS
XAIR
OUTLOOK RATING
1..100
2598
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8492
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5015

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (29) in the null industry is in the same range as CERS (34) in the Medical Specialties industry. This means that XAIR’s stock grew similarly to CERS’s over the last 12 months.

XAIR's Profit vs Risk Rating (100) in the null industry is in the same range as CERS (100) in the Medical Specialties industry. This means that XAIR’s stock grew similarly to CERS’s over the last 12 months.

CERS's SMR Rating (97) in the Medical Specialties industry is in the same range as XAIR (100) in the null industry. This means that CERS’s stock grew similarly to XAIR’s over the last 12 months.

CERS's Price Growth Rating (84) in the Medical Specialties industry is in the same range as XAIR (92) in the null industry. This means that CERS’s stock grew similarly to XAIR’s over the last 12 months.

CERS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as XAIR (100) in the null industry. This means that CERS’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSXAIR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRAB6.000.47
+8.50%
Grab Holdings Limited
DHX2.94N/A
N/A
DHI Group
HBNB2.94-0.02
-0.68%
Hotel101 Global Holdings Corp.
BRTX1.54-0.06
-3.75%
BioRestorative Therapies
AEO18.34-1.27
-6.48%
American Eagle Outfitters

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
+7.52%
OPK - XAIR
35%
Loosely correlated
-2.10%
KIDS - XAIR
32%
Poorly correlated
-3.34%
SHWGY - XAIR
32%
Poorly correlated
N/A
CERS - XAIR
31%
Poorly correlated
-1.60%
IDXX - XAIR
31%
Poorly correlated
-0.62%
More